Influence of Residual Astigmatism on Visual Acuity in Patients Undergoing Cataract Surgery With Trifocal Intraocular Lens Implantation
NCT ID: NCT04387721
Last Updated: 2020-05-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
48 participants
OBSERVATIONAL
2019-07-29
2021-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
SECONDARY OBJECTIVE: To study the influence of residual astigmatism on the visual quality of the patient in the far focus and to determine if there are differences of affectation in the two study groups.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Long-term Outcome After Toric Intraocular Lens Implantation
NCT05465447
Assessing the Astigmatism Reducing Effect With Toric IOLs in Eyeswith Low Astigmatism
NCT03538964
Comparison of Toric IOL Implantation and Opposite Clear Corneal Incision During Cataract Surgery to Correct Corneal Astigmatism
NCT01763151
Comparison of 2 Diffractive Trifocal IOLs
NCT03748381
Objective and Subjective Outcomes of a Trifocal IOL in Eyes With Different AL
NCT05431868
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Trifocal IOL(Finevision IOL, PhysIOL)
We will divide the sample into two groups of patients depending on the IOL implanted First group: FineVision
Kind of trifocal IOL
Patients will be divided between groups based on pre-surgery corneal astigmatism. Group FineVision is made up of patients with corneal astigmatism less than 1 D. Groups FineVision Toric is made up pf patients with corneal astigmatism more than 1.25 D
Trifocal toric IOL (Finevision Toric IOL, PhysIOL)
We will divide the sample into two groups of patients depending on the IOL implanted: Second group: FineVisionToric
Kind of trifocal IOL
Patients will be divided between groups based on pre-surgery corneal astigmatism. Group FineVision is made up of patients with corneal astigmatism less than 1 D. Groups FineVision Toric is made up pf patients with corneal astigmatism more than 1.25 D
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Kind of trifocal IOL
Patients will be divided between groups based on pre-surgery corneal astigmatism. Group FineVision is made up of patients with corneal astigmatism less than 1 D. Groups FineVision Toric is made up pf patients with corneal astigmatism more than 1.25 D
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* IOLs implanted IOLs FineVision (MicroF) and FineVision Toric (PodFT)
* Patients with pre-surgery corneal astigmatism less than 2.5 D
* Patients whose pupillary diameter in physiological position (conditions of lower photopic pupil) not over 4 mm.
Exclusion Criteria
* Previous corneal or intraocular surgeries
* Active diseases
* Eye complications during the 3-month follow-up
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Enrique Ordiñaga-Monreal, OD, MSc
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Enrique Ordiñaga-Monreal, OD, MSc
Clinical Optometrist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Enrique Ordiñaga-Monreal, OD
Role: PRINCIPAL_INVESTIGATOR
Clinica Oftalmologica TACIR
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinica Oftalmológica TACIR
Barcelona, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019/65-OFT-CMT
Identifier Type: OTHER
Identifier Source: secondary_id
EC042019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.